Clinical and experimental infection due to Aureobasidium pullulans: Study of pathogenicity of a clinical isolate for albino rats

Journal de Mycologie Medicale

Volumn 12, Issue 3, 2002, Pages 101-106

  Vishnoi, S ^a   Naidu, J ^a   Singh, S M ^a   Vishnoi, R ^a  

^a South Civil Lines ^*  (India)

Author keywords

Animal model; Aureobasidium pullulans; Invasive mycose; Neutropenic cancer patient

Indexed keywords

AGAR; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; CHLORAMPHENICOL; CORTISONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUREOBASIDIUM PULLULANS; CASE REPORT; CONTROLLED STUDY; CULTURE MEDIUM; FUNGUS CULTURE; FUNGUS ISOLATION; HUMAN; INOCULATION; KIDNEY; LIVER; LUNG; MALE; MYCOSIS; NEUTROPENIA; NONHUMAN; PATHOGENICITY; SEMINOMA; SPLEEN; TARGET ORGAN; TESTIS TUMOR;

EID: 0036746517     PISSN: 11565233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Aisner J, Schimpff SC, Bennett JE, Young VM, Wienik PH. Aspergillus infection in cancer patients: association with fire proofing materials in a new hospital. JAMA 1976;235:411.
2. Akagi M, Fujino T, Hayashi S, Yamamoto Y, Akabe T. A case of pulmonary infection caused by a black yeast like fungus. Med J Osaka Univ 1958;8:585-99.
3. Anaissie E, Bodey GP. Kanlarjian H, Ro J, Vartivarian SE, Hopfer R, Hoy J, Rolston K. New spectrum of fungal infection in patient with cancer. Rev Infect Dis 1989;11:369-78.
4. Badillet G. Les alternarioses cutanées. Revue de la litterature. J Mycol Med 1991;1:59-71.
5. Baker RD. Leukopenia and therapy leukemia as factors predisposing to fatal mycoses, mucormycosis, aspergillosis, cryptococcosis. Amer J Clin Path 1962;37:358-62.
6. Caporale NE, Calegari L, Perez D, Gezuele E. Peritoneal catheter colonization and peritonitis with Aureobasidium pullulans. Peritoneal Dialysis International 1996;16:97-8.
7. Clark EC, Silver SM, Hollick GE, Rinaldi MG. Continuous ambulatory peritoneal dialysis complicated by Aureobasidium pullulans peritonitis. American J Nephrology 1995;15:353-5.
8. Cook WB. An ecological life history of Aureobasidium pullulans (De Bary) Arnaud. Mycopathol Mycol Appl 1959;12:1-45.
9. Ibanez PR, Chacon J, Fidalgo A, Martin J, Paraiso V, Munoz-Bellido JL. Peritonitis by Aureobasidium pullulans in continuous ambulatory peritoneal dialysis. Nephrology Dialysis Transplantation 1997;12:1544-5.
10. Kaczmarski EB, Liu Yin JA, Tooth JA, Love EM, Delamore IW. Systemic infection with Aureobasidium pullulans in a leukemic patients. J Infect 1986;13:289-91.
11. Kwong-Chung KJ, Bennett JE. Medical Mycology, Lea and Febiger Publishers, Philadelphia, London, 1992.
12. Lerner CW, Tapper ML Opportunistic infection complicating acquired immunodeficiency syndrome. Clinical features of 25 cases. Medicine 1984;63:155-164.
13. Lopes JO, DeMello ES, Klock C. Mixed intranasal infection caused by Fusarium solani and a zygomycete in a leukemic patient. Mycoses 1995;38:281-4.
14. McGinnis MR. Laboratory Handbook of Medical Mycology, Academic Press, New York, 1980.
15. Powderly WG, Kobayashi GS, Herzig GP, Medoff G. Amphotericin-B resistant yeast infection in severely immunocompromised patients. Am J Med 1988;84:826-32.
16. Redondo-Bellon P, Idoate M, Rubio M, Ignacio Herrero J. Chromoblastomycosis produced by Aureobasidium pullulans in an immunosuppressed patient. Archives of Dermatology 1997;133:663-4.
17. Salkin JF, Martinez JA, Kemna ME. Opportunistic infection of the spleen caused by Aureobasidium pullulans. J Clin Microbiol 1986;23: 828-31.
18. Slavikova E, Vadkertiova R. Yeast and yeast like organism isolated from fish-pond waters. Acta Microbiologica Polonica 1995;44:181-9.
19. Tan HP, Wahlstrom HE, Zamora JU, Hassanein T. Aureobasidium pneumonia in a post liver transplant recipient: a case report. Hepato-Gastroenterology 1997;44:1215-8.
20. Trick WE, Jarvis WR. Epidemiology of nosocomial fungal infection in the 1990s. Rev Iberoam Micot 1998;15:2-6.
21. Trupl J, Minarik T, Spanik S, Sufliarsky J, Krcmery V Jr. Nosocomial bacterial and fungal meningitis in cancer patients. Supportive care in Cancer 1995;3:425-7.
22. Verhoef J, Peterson PK, Quie PG. (eds.). Infection in immunocompromised host pathogenesis, Prevention and Therapy. Elsevier, Amsterdam, 1980.
23. Wada Y. Kitajima H, Kubo M. A boy highly suspected of hypersensitivity pneumonitis characterized by generalized mucosal lesions [Japanese]. Niholz Rinsho Meneki Gakkai Kaishi 1996;19:524-36.
24. Wiest PM, Wiese K, Jacobs MR, Morrissey AB, Abelson TI, Wilt W, Lederman MM. Alternaria infection in a patient with acquired immunodeficiency syndrome: case report and review of invasive Alternaria infection. Rev Infect Dis 1987;9:799-803.
25. Wilson SJ, Everts RJ, Kirkland KB, Sexton D. A pseudo outbreak of Aureobasidium species lower respiratory tract infections caused by reuse of single-use stopcocks during bronchoscopy. Infect Control Hosp Epidemiol 2000;21:470-2.
26. Yarrish R, Sepulveda J, Tores R, Britton D. Invasive Aureobasidium infection in a patient with the acquired immunodeficiency syndrome. 7th International Conference on AIDS, Florence, Italy, June 16-21 1991, Instituto di Sanita Rome.